Evaluating Public Health Surveillance

Principles & Practice of Public Health Surveillance

Volumn , Issue , 2010, Pages

  Groseclose, Samuel L ^a   German, Robert R ^b   Nsubuga, Peter ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Criteria; Evaluation; Indicators; Monitoring; Objectives; Surveillance; Tools

Indexed keywords

EID: 84857342854     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195372922.003.0008     Document Type: Chapter

References (67)

1. Centers for Disease Control and Prevention. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR Recomm Rep 2001;50(RR-13):1-35. . Accessed January 30, 2009.
2. World Health Organization. Communicable disease surveillance and response systems:guide to monitoring and evaluating. 2006. WHO/CDS/EPR/LYO/2006.2. . Accessed January 30, 2009.
3. World Health Organization Regional Office for Africa, Division of Communicable Disease Prevention and Control. Guide for the Use of Core Integrated Disease Surveillance and Response Indicators in the African Region. June 2005. . Accessed January 30, 2009.
4. Hall HI, Mokotoff ED, Advisory Group for Technical Guidance on HIV/AIDS Surveillance. Setting standards and an evaluation framework for human immunodeficiency virus/acquired immunodeficiency syndrome surveillance. J Public Health Manag Pract 2007; 13:519-523.
5. Potter MA, Sweeney P, Iuliano AD, Allswede MP. Performance indicators for response to selected infectious disease outbreaks: a review of the published record. J Public Health Manag Pract 2007; 13:510-518.
6. Roush SW, Wharton M. Surveillance indicators. In: Roush SW, McIntyre L, Baldy LM, eds. Manual for the Surveillance of Vaccine-Preventable Diseases, 4th ed. Atlanta, GA:Centers for Disease Control and Prevention; 2008. . Accessed January 30, 2009.
7. Wilkins K, Nsubuga P, Mendlein J, Mercer D, Pappaioanou M. The Data for Decision Making project: assessment of surveillance systems in developing countries to improve access to public health information. Public Health 2007;doi:10.1016/j.puhe.2007.11.002.
8. McNabb SJN, Surdo AM, Redmond A, et al. Applying a new conceptual framework to evaluate tuberculosis surveillance and action performance and measure the costs, Hillsborough County, Florida, 2002. Ann Epidemiol 2004; 14:640-645.
9. World Health Organization. Protocol for the evaluation of epidemiological surveillance systems. 1997. WHO/EMC/DIS/97.2. . Accessed January 30, 2009.
10. World Health Organization. An integrated approach to communicable disease surveillance. Wkly Epidemiol Rec 2000; 75:1-8.
11. Nsubuga P, Eseko N, Wuhib T, Chungong S, Ndayimirije N, McNabb S. Structure and performance of infectious disease surveillance, Tanzania 1998. Bull World Health Organ 2002; 80:196-203.
12. Centers for Disease Control and Prevention. Assessment of infectious disease surveillance-Uganda, 2000. MMWR 2000;49;687-691.
13. Wu TSJ, Shih FYF, Yen MY, et al. Establishing a nationwide emergency departmentbased syndromic surveillance system for better public health responses in Taiwan. BMC Public Health 2008; 8:18.
14. Shannon JJ, Catrambone CD, Coover L. Targeting improvements in asthma morbidity in Chicago: a 10-year retrospective of community action. Chest 2007; 132:866-873.
15. Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES). Med Care 2007;45:S96-S102.
16. Meyer N, McMenamin J, Robertson C, Donaghy M, Allardice G, Cooper D. A multidata source surveillance system to detect a bioterrorism attack during the G8 Summit in Scotland. Epidemiol Infect 2008; 136:876-885.
17. Schenkel K, Williams C, Eckmanns T, et al. Enhanced surveillance of infectious diseases: the 2006 FIFA World Cup Experience, Germany. Euro Surveill 2006;11:ii-670.
18. Thacker SD, Stroup DF, Carande-Kulis V, Marks JS, Roy K, Gerberding JL. Measuring the public's health. Public Health Rep 2006; 121:14-22.
19. Murray CJL, Salomon J, Mathers DC, Lopez AD, Lozano R, eds. Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications. Geneva: World Health Organization, 2002. . Accessed January 30, 2009.
20. Michaud CM, McKenna MT, Gegg S, et al. The burden of disease and injury in the United States, 1996. Popul Health Metr 2006;4:11. . Accessed January 30, 2009.
21. Mather CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e42-e442. . Accessed January 30, 2009.
22. Curry CW, De AK, Ikeda RM, Thacker SB. Health burden and funding at the Centers for Disease Control and Prevention. Am J Prev Med 2006; 30:269-276.
23. Keppel KG. Ten largest racial and ethnic health disparities in the United States based on Healthy People 2010 Objectives. Am J Epidemiol 2007; 166:97-103.
24. Haddix A, Teutsch S, Corso P, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation, 2nd ed. New York: Oxford University Press; 2002.
25. Kimmel SR. Addressing immunization barriers, benefits, and risks. J Fam Pract 2007;56:S51-S69.
26. Buckeridge DL, Thompson MW, Babin S, Sikes ML. Evaluating automated surveillance systems. In: Lombardo JS, Buckeridge DL, eds. Disease Surveillance: a Public Health Informatics Approach. Hoboken, NJ: John Wiley & Sons;. 2007:399-424.
27. Centers for Disease Control and Prevention. Framework for evaluating public health surveillance systems for early detection of outbreaks; recommendations from the CDC Working Group. MMWR Recomm Rep 2004;53(RR-5):1-13.
28. Miller M, Roche P, Spencer J, Deeble M. Evaluation of Australia's National Notifiable Disease Surveillance System. Commun Dis Intell 2004; 28:311-323.
29. Council of State and Territorial Epidemiologists. Asthma Surveillance and Case Definition. Position Statement 1998-EH/CD 1. . Accessed January 30, 2009.
30. Thomsen C, McClain J, Rosenman K, Davis L. Indicators for occupational health surveillance. MMWR Recomm Rep 2007;56(RR-1):1-7.
31. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. . Accessed January 30, 2009.
32. Centers for Disease Control and Prevention, Council of State and Territorial Epidemiologists, Association of State and Territorial Chronic Disease Program Directors. Indicators for Chronic Disease Surveillance. MMWR Recomm Rep. 2004;53(RR11);1-6. . Accessed January 30, 2009.
33. Wild EL, Hastings TM, Gubernick R, Ross DA, Fehrenbach SN. Key elements for successful integrated health information systems: lessons from the states. J Public Health Manag Pract 2004;11(Suppl):S36-S47.
34. Williams W, Lyalin D, Wingo PA. Systems thinking: what business modeling can do for public health. J Public Health Manag Pract 2005; 11:550-553.
35. Public Health Informatics Institute. Taking Care of Business: A Collaboration to Define Local Health Department Business Processes. Decatur, GA: Public Health Informatics Institute; 2006.
36. Kitch P, Yasnoff WA. Assessing the value of information systems. In: O'Carroll PW, Yasnoff WA, Ward ME, Ripp LH, Martin EL, eds. Public Health Informatics and Information Systems. New York: Springer-Verlag; 2003:114-158.
37. Somda ZC, Meltzer MI, Perry HN. SurvCost 1.0: A Manual to Assist Country and District Public Health Officials in Estimating the Cost of the Implementation of Integrated Disease Surveillance and Response Systems (Beta Test Version). Atlanta, GA:Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2007. . Accessed January 30, 2009.
38. Morris S, Gray A, Noone A, Wiseman M, Jathanna S. The costs and effectiveness of surveillance of communicable disease: a case study of HIV and AIDS in England and Wales. J Public Health Med 1996; 18:415-422.
39. Tebbens RJD, Sangrujee N, Thompson KM. The costs of future polio risk management policies. Risk Anal 2006; 26:1507-1531.
40. Kirkwood A, Fleishchauer AT, Gunn J, Hutwagner L, Barry MA. Direct cost associated with the development and implementation of a local syndromic surveillance system. J Public Health Manag Pract 2007; 13:194-199.
41. Bravata DM, McDonald KM, Szeto H, Smith WK, Rydzak C, Owens DK. A conceptual framework for evaluating information technologies and decision support systems for bioterrorism preparedness and response. Med Decis Making 2004; 24:192-206.
42. Doroshenko A, Cooper D, Smith G, et al. Evaluation of syndromic surveillance based on National Health Service Direct derived data-England and Wales. MMWR 2005;54(Suppl.):117-122.
43. Bravata DM, McDonald KM, Smith WM, et al. Systematic review: Surveillance systems for early detection of bioterrorism-related diseases. Ann Intern Med 2004; 140:910-922.
44. Overhage JM, Grannis S, McDonald CJ. A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifiable conditions. Am J Public Health 2006; 98:344-350.
45. Dailey L, Watkins RE, Plant AJ. Timeliness of data sources used for influenza surveillance. J Am Med Inform Assoc 2007; 14:626-631.
46. Hedberg CW, Greenblatt JF, Matyas BT, et al. Timeliness of enteric disease surveillance in 6 US states. Emerg Infec Dis 2008; 14:311-313.
47. Vogt RL, Spittle R, Cronquist A, Patnaik JL. Evaluation of timeliness and completeness of a web-based notifiable disease reporting system by a local health department. J Public Health Manag Pract 2006; 12:540-544.
48. Ihekweazu C, Maxwell N, Organ S, Oliver I. Is STI surveillance in England meeting the requirements of the 21st century? An evaluation of data from the Southwest Region. Euro Surveill 2007;12(5):ii-708.
49. Hopkins RS. Design and operation of state and local infectious disease surveillance systems. J Public Health Manag Pract 2005; 11:184-190.
50. German RR. Sensitivity and predictive value positive measurements for public health surveillance systems. Epidemiology 2000; 11:720-727.
51. Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev 1995; 17:243-264.
52. O'Carroll PW. Introduction to public health informatics. In: O'Carroll PW, Yasnoff WA, Ward ME, Ripp LH, Martin EL, eds. Public Health Informatics and Information Systems. New York: Springer-Verlag; 2003:3-15.
53. Lewis D. Evaluation for public health informatics. In: O'Carroll PW, Yasnoff WA, Ward ME, Ripp LH, Martin EL, eds. Public Health Informatics and Information Systems. New York: Springer-Verlag; 2003:239-250.
54. Ashurst C, Doherty NF. Towards the formulation of a 'best practice' framework for benefits realisation in IT projects. Electronic J Information Systems Evaluation. 2003; 6:1-10.
55. DeLone WH, McLean ER. The DeLone and McLean model of information systems success: a ten-year update. J Manag Information Systems 2003; 19:9-30.
56. Public Health Informatics Institute. Towards Measuring Value: An Evaluation Framework for Public Health Information Systems. Decatur, GA: Public Health Informatics Institute Technical Report; April 2005.
57. Ammenwerth E, Graber S, Herrmann G, Burkle T, Konig J. Evaluation of health information systems-problems and challenges. Int J Med Inform 2003; 71:125-135.
58. Amato-Gauci A, Ammon A. The surveillance of communicable diseases in the European Union - a long-term strategy (2008-2013). Euro Surveill 2008;13(26):ii-18912. . Accessed January 30, 2009.
59. Centers for Disease Control and Prevention. Progress in improving state and local disease surveillance-United States, 2000-2005. MMWR 2005;54;822-825.
60. Kivi M, Koedijk FDH, van der Sande M, van de Laar MJ. Evaluation prompting transition from enhanced to routine surveillance of lymphogranuloma venereum (LGV) in the Netherlands. Euro Surveill 2008;13(14):ii-8087.
61. Schaefer MK, Shehab N, Cohen AL, Budnitz DS. Adverse events from cough and cold medications in children. Pediatrics 2008; 121:783-787.
62. Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008; 47:735-743.
63. Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007; 147:755-765.
64. Bingle CL, Picard L, Holowaty PH, Stewart PJ, Koren IE, Feltis SL. An evaluation of the Ontario Rapid Risk Factor Surveillance System. Can J Public Health 2005; 96:145-150.
65. Wolkin AF, Patel M, Watson W, et al. Early detection of illness associate with poisoning of public health significance. Ann Emerg Med 2006; 47:170-176.
66. Meynard JB, Chaudet H, Green AD, et al. Proposal of a framework for evaluating military surveillance systems for early detection of outbreaks on duty areas. BMC Public Health 2008; 8:146.
67. Braun KVN, Pettygrove S, Daniels J, et al. Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders-Autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ 2007;56(SS-1):29-40.